A step towards the ambition of precision oncology in recurrent ovarian cancer
10.3802/jgo.2022.33.e64
Saved in:
Main Authors: | Wijaya, Silvana Talisa, Tan, David Shao Peng |
---|---|
Other Authors: | MEDICINE |
Format: | Editorial |
Language: | English |
Published: |
KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/231537 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers
by: Ngoi, Natalie YL, et al.
Published: (2021) -
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
by: Ngoi, Natalie YL, et al.
Published: (2020) -
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
by: Marijon, Hélène, et al.
Published: (2022) -
Polycystic Ovarian Syndrome Issue-30.8 Preface
by: Yong, Eu-Leong
Published: (2021) -
Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
by: Lee, Matilda X, et al.
Published: (2021)